I think most of you overlooked one important hint - JP mentioned that Acadia is more likely to use Trofinetide for other indications other than Fragile X and Neuren would still get the loyalties. This suggests to me that acacia is actively looking into using Trofinetide for other indications which could be another big revenue stream for NEU
Moonsoon Briefing Thurs 20 April, page-70
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |